About Adribin 2 mg/ml IV Infusion
Adribin 2 mg/ml is a iv infusion product of Healthcare Pharmaceuticals Ltd. that contains Doxorubicin Hydrochloride. Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for: Ovarian cancer : After failure of platinum-based chemotherapy.
There are 2 brands of Doxorubicin Hydrochloride listed in Bangladesh. By unit price, Adribin is among the cheapest of them.
What is Adribin 2 mg/ml IV Infusion?
Adribin 2 mg/ml is a iv infusion product of Healthcare Pharmaceuticals Ltd. that contains Doxorubicin Hydrochloride. Read more Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for: Ovarian cancer : After failure of platinum-based chemotherapy. Multiple Myeloma : In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy. Ask your doctor or pharmacist if you are unsure about it.
Uses of Adribin
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for: Ovarian cancer : After failure of platinum-based chemotherapy. Multiple Myeloma : In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy. Ask your doctor whether it is right for your condition.
How to use Adribin
Take Adribin exactly as prescribed by your doctor. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Adribin
Leucopenia, thrombocytopenia, nausea, vomiting, diarrhoea. Blurred vision, headache, seizures, paraesthesia, confusion, malaise, lethargy, skin pigmentation. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Severe myelosuppression due to previous treatment with antitumour agents or radiotherapy. Cardiac disease, neonates, pregnancy and lactation, prior irradiation to mediastinum. Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Adribin treat?
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for: Ovarian cancer : After failure of platinum-based chemotherapy. Multiple Myeloma : In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
How do I use Adribin correctly?
Take Adribin exactly as prescribed by your doctor. Complete the course exactly as prescribed.
What are the side effects of Adribin?
Leucopenia, thrombocytopenia, nausea, vomiting, diarrhoea. Blurred vision, headache, seizures, paraesthesia, confusion, malaise, lethargy, skin pigmentation.
How much does Adribin cost in Bangladesh?
The listed price is ৳ 350.00.
- Strength
- 2 mg/ml
Price in Bangladesh
৳ 343 ৳ 350.00 2% off unit price
Price updated: 1 Jul 2022
Indications
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for:
- Ovarian cancer: After failure of platinum-based chemotherapy.
- AIDS-related Kaposi’s Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy.
... Read more
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for:
- Ovarian cancer: After failure of platinum-based chemotherapy.
- AIDS-related Kaposi’s Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy.
- Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
Pharmacology
Doxorubicin is a cytotoxic anthracycline antibiotic. The cytotoxic action results from its binding to DNA and inhibition of nucleic acid synthesis. Doxorubicin has been shown to produce regression in a variety of disseminated malignancies.
Dosage & Administration
Administer Doxorubicin at an initial rate of 1 mg/min to minimize the risk of infusion reactions. If no infusion related reactions occur, increase rate of infusion to complete administration over 1 hour. Do not administer as bolus injection or undiluted solution.
- Ovarian cancer: 50 mg/m2 IV every 4 weeks
- AIDS-related Kaposi’s Sarcoma: 20 mg/m2 IV every 3 weeks
- Multiple Myeloma: 30 mg/m2 IV on day 4 following bortezomib
Interaction
Doxorubicin interacts with a number of other drugs e.g. antibiotics (aminoglycosides), steroids, aminophylline and propranolol.
Contraindications
Cardiac disease, neonates, pregnancy and lactation, prior irradiation to mediastinum. IM/SC admin. Severe myelosuppression due to previous treatment with antitumour agents or radiotherapy.
Side Effects
Leucopenia, thrombocytopenia, nausea, vomiting, diarrhoea. Rarely facial flushing, rash, alopecia. Blurred vision, headache, seizures, paraesthesia, confusion, malaise, lethargy, skin pigmentation.
Pregnancy & Lactation
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Precautions & Warnings
Elderly, children, hepatic impairment. Monitor blood counts and ECG.
Overdose Effects
Acute overdosage may increase the toxic effects of mucositis, leukopenia and thrombocytopenia. Treatment includes hospitalisation of the severely myelosuppressed patient, antimicrobials, platelet transfusions and symptomatic treatment of mucositis. Use of haemopoietic growth factor (G-CSF, GM-CSF) may be considered. Cumulative dosage increases risk of cardiomyopathy and resultant congestive heart failure which may be managed with digitalis preparations, diuretics, and after load reducers such as ACE inhibitors.
Storage Conditions
Powder for injection: Store at 15-30°C.
Solution for injection & liposomal formulations: Refrigerate at 2-8°C. Do not freeze.
Alternative brands of Doxorubicin Hydrochloride
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.